Frank Heinricht

CEO, Schott, Mainz, DE

Frank Heinricht was born in 1962, in Berlin, Germany. After completing a degree in physics and a doctorate in engineering at the Technical University of Berlin, he began his professional career in business in 1992.

He has been Chairman of the Management Board of SCHOTT AG from June 2013, being responsible for the Business Units Pharmaceutical Packaging and Tubing as well as for the Corporate Functions Research and Development, Compliance and Legal, Human Resources, Marketing and Communication, Strategic Development.

In addition, he is also a vice-chairman of the Supervisory Board of the Würth Group, member of the Supervisory Board of B. Braun SE, President of the Federal Association of the German Glass Industry (BV Glas), Member of the Presidential Board of The Federation of German Industries (BDI) and Member of the German Science Council (Wissenschaftsrat).

9:00 - 9:30 AM

Day - 2 11 Feb

Glass – an enabler in life science and pharma

Asking about life science and pharma nobody would naturally come up with glass as an enabler. But with a closer look it gets rather obvious, that without glass there would be no modern life science or pharma.

Starting with the microscope empowered by Otto Schott with designed optical glasses, this was and is a key still today: from the invention of Penicillin over understanding the cell division mechanisms until latest gene technologies – the indispensable micro insights would not be possible without specialty glass.

Another area for glass as hidden champion is state-of-the-art medical treatment technology: endoscopy or minimally invasive surgery are widely known and applied, but rarely it’s recognized the role of glass in such technology.

Once someone gets a drug injection, it is taken of course as given, that no contaminants or particles come along potentially harming the state of health. Safe drug storage and transportation is prerequisite and there glass is really a hero! But modern pharmacology is continuously challenging glass e.g. in areas like mRNA drugs or individual cancer therapy, so reinventing of glass never will stop.

Therefore one can expect for sure in the future further breakthrough achievements for the sake of human wellbeing!